{{ phone }} {{ location }}

Emergo by UL logo

         

NMPA

Chinese Regulators Continue Adding Medical Devices, IVDs to Clinical Trial Exemption List

EMERGO SUMMARY OF KEY POINTS:

  • China’s National Medical Products Administration (NMPA) has expanded its list of medical devices and IVDs exempt from clinical trial requirements for the second time in 2018.
  • NMPA now exempts more than 1,200 products from clinical trial requirements in China.